By SwimScore. Medically reviewed by [reviewer name and credentials to be added before publishing]. Last updated October 6, 2026.
Key Takeaways
Azoospermia is the medical term for a semen sample with no sperm in it, and it is found in roughly 10 to 15 percent of men who seek care for couple infertility (Corona et al., Human Reproduction Update, 2019).
Azoospermia has two very different causes: a blockage that stops sperm from leaving the body, which usually means sperm are still being made, and a production problem inside the testes, which is called non-obstructive azoospermia and has far less predictable odds.
SwimScore Complete does not diagnose or treat azoospermia, but its semen analysis and hormone panel (FSH, LH, and testosterone, measured at a CLIA-certified lab) give a man and his clinician the first pieces of the pattern that separates the two types.
A semen analysis report that says "no sperm seen" is one of the most frightening results a man can get. Most of the internet reads it as a verdict. It is not one. Azoospermia is a category, and the two main types inside it have almost nothing in common when it comes to what happens next. Some men with azoospermia have a good chance of fatherhood using their own sperm. Some have a modest chance. A small group, defined by specific genetic findings, have almost none. The job of this article is to explain which is which, in plain English, and to be honest about where the numbers are less solid than the clinic brochures suggest.
What is azoospermia?
Azoospermia is a semen sample in which no sperm are found, even after the lab spins the sample in a centrifuge (a machine that concentrates anything solid to the bottom of the tube) and examines what settles out. A single result like this should be repeated on a second sample before anyone draws conclusions, because a sample can be incomplete, collected wrongly, or affected by a recent illness or medication. It is the most severe version of male-factor infertility, and in a 2019 meta-analysis it was described as occurring in 10 to 15 percent of men seeking medical care for couple infertility (Corona et al., Human Reproduction Update, 2019, doi:10.1093/humupd/dmz028).
What is the difference between obstructive and non-obstructive azoospermia?
Obstructive azoospermia means sperm are being made but cannot get out, while non-obstructive azoospermia means the testes are not making enough sperm for any to show up in the ejaculate. Think of a factory and a loading dock. In obstructive azoospermia the factory is running normally, but the loading dock is blocked. In non-obstructive azoospermia the dock is open, but the factory is producing little or nothing.
Obstructive azoospermia is usually characterized by normal sperm production inside the testes, according to the same 2019 meta-analysis. The blockage is in the tubes that carry sperm out. The most familiar example is a vasectomy, which deliberately cuts the vas deferens, the tube that carries sperm from each testicle. Others include scarring from infection or surgery, and a condition some men are born with called congenital bilateral absence of the vas deferens, or CBAVD, where both tubes are missing. A 2022 review in Frontiers in Genetics reports that CBAVD accounts for 1 to 2 percent of male infertility cases and is most often caused by changes in a gene called CFTR, the same gene behind cystic fibrosis (Cai and Li, Frontiers in Genetics, 2022, PMC8873976).
Non-obstructive azoospermia is a much more varied picture. The testes may be making sperm at very low levels that never reach the ejaculate, may stall partway through sperm development, or may contain almost no sperm-producing cells at all. Causes include genetic conditions such as Klinefelter syndrome (an extra X chromosome) and missing pieces of the Y chromosome, as well as damage from an undescended testicle, mumps, torsion, chemotherapy, or radiation. Testosterone replacement therapy can also produce azoospermia, because it switches off the brain's signal to the testes. That cause is different from the others because it is often reversible, and we cover it in TRT-induced infertility and recovering fertility after TRT.
What do the odds look like when sperm are made but blocked?
When the problem is a blockage, a man's own sperm can usually be collected and used, and the odds depend heavily on the route chosen. For a man who has had a vasectomy, a 2018 retrospective study at a single center compared 163 couples: 99 chose surgical reversal and 64 went straight to IVF with ICSI (a procedure in which one sperm is injected directly into an egg). The crude cumulative delivery rate was 49.5 percent in the reversal pathway and 43.8 percent in the immediate IVF pathway, and the difference was not statistically significant. The IVF route got couples to pregnancy faster, an average of 8.2 months versus 16.3 months (Valerie et al., Human Reproduction, 2018, Human Reproduction 33(7):1218). This was a retrospective study at one center, not a randomized trial, so it shows that both routes work rather than proving one beats the other.
The practical point is that obstructive azoospermia is the "good news" category, but it is not a guarantee. The partner's age and fertility matter as much as they do for any couple, and congenital causes such as CBAVD call for genetic counseling for both partners, since the Frontiers in Genetics review notes that CFTR changes in a female partner can affect outcomes and the risk of passing a condition to a child (Cai and Li, Frontiers in Genetics, 2022).
What do the odds look like when the testes are not making enough sperm?
For non-obstructive azoospermia, surgeons can find sperm directly in the testicle in roughly half of attempts, and about one ICSI cycle in four ends in a live birth. A 2019 systematic review and meta-analysis pooled 117 studies with 21,404 men with non-obstructive azoospermia and found sperm was retrieved in 47 percent of procedures (95% confidence interval 45 to 49 percent). Across the 42 studies that reported ICSI results, the live birth rate was 24 percent per ICSI cycle (95% confidence interval 20 to 28 percent) (Corona et al., Human Reproduction Update, 2019).
The surgery in question is testicular sperm extraction, or TESE. In its refined form, called micro-TESE, the surgeon uses an operating microscope to hunt for the small sperm-producing tubes that look healthier than the rest. Micro-TESE is widely described as the preferred technique, yet in this meta-analysis it did not outperform the older, simpler approach: sperm retrieval was 46 percent for both. The authors themselves say a properly designed randomized trial is still needed to settle it. We mention this because many clinic pages state micro-TESE superiority as fact. The pooled data do not show it.
The same analysis found that retrieval chances were higher in men with larger testicles. A mean testis volume above 12.5 mL predicted a retrieval rate above 60 percent, with an accuracy of 86.2 percent in the authors' ROC analysis (a statistical way of testing how well a number separates good outcomes from poor ones). Hormone levels at enrollment, including FSH, did not predict retrieval in the meta-regression, which surprises many men who have been told a high FSH means no chance. Keep in mind that this analysis pooled many studies and looked at averages across them, so it does not tell any individual man where he stands. It does mean that a hormone number alone should not be used to talk a man out of a surgical attempt.
Does the specific genetic cause change the odds?
Yes, and genetic testing is one of the most useful steps in a non-obstructive workup because it sorts men into very different groups. Two causes matter most.
The first is Klinefelter syndrome. A 2017 meta-analysis of 37 studies and 1,248 men with Klinefelter syndrome found sperm retrieval rates close to 50 percent, with a pregnancy rate of 43 percent (95% confidence interval 36 to 50 percent) across 410 ICSI cycles and a live birth rate of 43 percent (95% confidence interval 34 to 53 percent) (Corona et al., Human Reproduction Update, 2017, PMID 28379559). That is a better ICSI outcome than the non-obstructive group as a whole, though the surgery is still needed to get there.
The second is missing pieces of the Y chromosome, called Y chromosome microdeletions. The Y chromosome carries genes sperm development depends on, and three regions are tested, called AZFa, AZFb, and AZFc. A 2020 study from Japanese fertility centers screened 2,163 men and found AZF deletions in 201 of them (9.3 percent). Among men with AZFc deletions who had micro-TESE, sperm were found in 74 percent (37 of 50), compared with 20.4 percent (109 of 534) in men without an AZF deletion. Among the couples using AZFc sperm, the clinical pregnancy rate was 29.3 percent per embryo transfer (27 of 92 transfers), with a miscarriage rate of 22.2 percent (Yamaguchi et al., Reproductive Medicine and Biology, 2020, doi:10.1002/rmb2.12317). The same paper notes that, with very few exceptions reported in the literature, a complete deletion of AZFa or AZFb means the chance of retrieving sperm is virtually zero. A man who tests positive for that finding can then avoid an operation that will not help him and move straight to other options, such as donor sperm or adoption.
One caution on the AZFc result: a deletion in that region can be passed to a son, so a man who has children by this route should know his sons may face the same problem.
What are we more skeptical about?
We are skeptical of three things that circulate around azoospermia. The first is the idea that a single hormone number decides everything. The meta-analysis above found no effect of hormones on retrieval rates, so a high FSH is a reason for a full workup, not a reason to give up. The second is the claim that one surgical technique is clearly superior, which the pooled data do not support. The third is the promise, common on supplement and wellness sites, that diet or supplements can turn non-obstructive azoospermia around. We found no randomized trial showing that, and supplement trials in general have not shown improved pregnancy or live birth rates. Supplements are not a treatment for azoospermia. The exceptions are the reversible hormonal causes, such as testosterone therapy or a pituitary problem, which a clinician can identify and treat directly.
We are also honest about what the numbers above cannot tell us. Most of the pooled data come from retrospective studies, the men in them differ widely in cause, age, and surgical skill of the center, and fewer than one live birth in three per ICSI cycle is an average, not a prediction for any one man. Pregnancy also depends on the partner's age and egg quality, which no sperm test can measure.
What should a man with a zero-sperm result do next?
The next step is a repeat semen analysis and a visit with a urologist or andrologist (a doctor who specializes in male reproductive health), who will examine the testicles and the tubes, review the hormone panel, and usually order genetic testing. A hormone panel is part of this: an FSH, LH, and testosterone result tells a clinician whether the signal from the brain is working. Patterns in those numbers can point toward a brain-signal problem or a testicle problem, as we explain in low testosterone with high LH versus normal LH and what your FSH level is telling you, though, as noted above, no single hormone settles the question of sperm retrieval.
For men who have not yet had a diagnosis, knowing is better than guessing. SwimScore Complete combines a CLIA-certified semen analysis, DNA fragmentation testing, and a hormone panel, so a man can bring a full picture to his clinician instead of a single flagged number. You can learn more at SwimScore Complete. Clinics that want a standardized report for their male-factor patients can see how it works on our for clinics page.
Our Take
We know that azoospermia is two conditions wearing one name, and that finding out which one a man has is the single most important step. When the cause is a blockage, outcomes are often good and the choice is between reversal and sperm retrieval with ICSI. When the cause is non-obstructive, about half of men have retrievable sperm and about one ICSI cycle in four produces a live birth, with real variation by testicle size and genetic cause.
We do not know whether micro-TESE beats conventional TESE, we cannot predict from a blood test who will have sperm, and we cannot promise that any approach will lead to a baby. Those are real gaps, and a clinic that sounds certain about them is selling something.
It is still worth acting, because the worst outcome is not a bad result. It is a result nobody ever followed up. A repeat sample, a hormone panel, a physical exam, and genetic testing are inexpensive compared with a surgical attempt, and they decide whether surgery makes sense in the first place.
Frequently Asked Questions
Can a man with azoospermia still have a biological child?
Often, yes. In obstructive azoospermia sperm production is usually normal and sperm can be collected for ICSI. In non-obstructive azoospermia, a 2019 meta-analysis found sperm was retrieved in 47 percent of procedures and about 24 percent of ICSI cycles led to a live birth (Corona et al., Human Reproduction Update, 2019).
What is the difference between obstructive and non-obstructive azoospermia?
Obstructive azoospermia means sperm are made but blocked from leaving the body. Non-obstructive azoospermia means the testes are not making enough sperm for any to reach the ejaculate.
Does a high FSH mean there is no chance of finding sperm?
Not by itself. A 2019 meta-analysis of 117 studies found that hormone levels at enrollment did not predict sperm retrieval rates, though larger testicle volume did (Corona et al., Human Reproduction Update, 2019).
Is micro-TESE better than regular TESE?
The pooled data do not show it. In the 2019 meta-analysis sperm retrieval was 46 percent for both techniques, and the authors called for a randomized trial to settle the question (Corona et al., Human Reproduction Update, 2019).
Can a Y chromosome microdeletion rule out sperm retrieval?
Complete deletions of the AZFa or AZFb regions mean the chance of finding sperm is virtually zero, while AZFc deletions had a 74 percent retrieval rate in one 2020 Japanese study (Yamaguchi et al., Reproductive Medicine and Biology, 2020).
References
1. Corona G, Minhas S, Giwercman A, et al. Sperm recovery and ICSI outcomes in men with non-obstructive azoospermia: a systematic review and meta-analysis. Human Reproduction Update, 2019;25(6):733-757. doi:10.1093/humupd/dmz028
2. Corona G, et al. Sperm recovery and ICSI outcomes in Klinefelter syndrome: a systematic review and meta-analysis. Human Reproduction Update, 2017. PubMed 28379559
3. Yamaguchi K, Ishikawa T, Mizuta S, et al. Clinical outcomes of microdissection testicular sperm extraction and intracytoplasmic sperm injection in Japanese men with Y chromosome microdeletions. Reproductive Medicine and Biology, 2020. doi:10.1002/rmb2.12317
4. Valerie U, De Brucker S, De Brucker M, et al. Pregnancy after vasectomy: surgical reversal or assisted reproduction? Human Reproduction, 2018;33(7). Human Reproduction 33(7):1218
5. Cai Z, Li H. Congenital bilateral absence of the vas deferens. Frontiers in Genetics, 2022. PMC8873976
This is general education and not medical advice. Azoospermia should be evaluated and managed by a urologist or andrologist.
SwimScore uses CLIA-certified labs for all semen analysis and hormone testing, assessed against WHO 6th Edition clinical thresholds.
